Actively Recruiting

Age: 18Years - 90Years
All Genders
Healthy Volunteers
ID06503341

Assessment and Control of Modifiable Risk Factors for Primary and Secondary Prevention in Cardiovascular Disease

Led by National Institute of Cardiovascular Diseases, Pakistan · Updated on 2026-04-13

10000

Participants Needed

1

Research Sites

521 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are observing patients at preventive cardiology clinics to better understand how cardiovascular risk assessment tools can be used most effectively. The study aims to explore how these tools influence the risk of cardiovascular disease (CVD) and related outcomes, focusing on both primary and secondary prevention. This ongoing research collects data to help clinicians develop personalized, effective treatment plans by combining individual risk factors. The study involves adult patients attending the National Institute of Cardiovascular Diseases (NICVD) in Karachi, Pakistan. It gathers detailed information such as demographic data, physical exams, clinical history, risk modifications, laboratory tests, and risk scores like the ASCVD and WHO Cardiovascular Risk scores. These assessments are recorded at the first visit and during follow-ups to track changes over time. Participants provide verbal consent and are followed over a long period, with data collection continuing regularly. Researchers analyze this information to measure cardiovascular risk over ten years, changes in risk levels, and cardiovascular-related deaths. The study uses structured questionnaires and statistical methods to evaluate the findings, aiming to contribute valuable insights into cardiovascular disease prevention and management.

CONDITIONS

Brief Title

A Hospital-Based Registry of Preventive Cardiology Clinics

Who Can Participate

Age: 18Years - 90Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • All individuals attending the preventive cardiology clinics.
Not Eligible

You will not qualify if you...

  • Individuals who refused to give consent.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Monitoring

Duration - Up to 10 years

Participants who undergo routine care are observed with cardiovascular risk assessments at presentation and during follow-up visits.

Follow-up visits as scheduled by the preventive cardiology clinics

Trial Site Locations

Total: 1 location

1

National Institute of Cardiovascular Diseases

Karachi, Sindh, Pakistan, 75510

Actively Recruiting

Loading map...

Research Team

D

Dr Rubina Rauf

M

Musa Karim

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

The Role of Akkermansia Muciniphilia in Combating the Metabo...

Prostate Cancer

Actively Recruiting

1 location

Arterial Stiffening as a Predictor for Diastolic Cardiac Dys...

Heart Failure With Preserved Ejection Fraction

Actively Recruiting

1 location

Diagnosis of Transient Ischemic Attacks in the Emergency Dep...

Transient Ischemic Attack

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Primary prevention of cardiovascular diseases among women in a South Asian population: a descriptive study of modifiable risk factors.

Rubina Rauf, Muhammad Nauman Khan, Jawaid Akbar Sial...

https://pubmed.ncbi.nlm.nih.gov/39542488